DPT-Hib vaccine
Подписчиков: 0, рейтинг: 0
| Combination of | |
|---|---|
| Diphtheria vaccine | Vaccine |
| Tetanus vaccine | Vaccine |
| Pertussis vaccine | Vaccine |
| Hib vaccine | Vaccine |
| Clinical data | |
| Trade names | Tetramune |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Routes of administration |
Intramuscular injection |
| ATC code | |
DPT-Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and whole-cell pertussis vaccine adsorbed with Hib conjugate vaccine, sometimes abbreviated to DPT-Hib. It protects against the infectious diseases diphtheria, tetanus, pertussis, and Haemophilus influenzae type B.
A branded formulation was marketed in the US as Tetramune by Lederle Praxis Biologicals (subsequently acquired by Wyeth). Tetramune has since been discontinued.
| Development | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Classes | |||||||||||
| Administration | |||||||||||
| Vaccines |
|
||||||||||
| Inventors/ researchers |
|||||||||||
| Controversy | |||||||||||
| Related | |||||||||||
| |||||||||||